Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Predictions

$18.44
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 13 May 2024

TRIL Predictions History

4 years ago
JS predicted that TRIL for 2020-02-24 is going $4.26 (8.67%)

4 years ago
JS predicted that TRIL for 2020-02-18 is going $3.36 (-2.33%)

4 years ago
Sorin Paul predicted that TRIL for 2020-02-06 is going

Rank:

4 years ago
JS predicted that TRIL for 2020-02-03 is going $3.40 (-16.87%)

4 years ago
JS predicted that TRIL for 2020-01-23 is going $3.91 (-7.35%)

4 years ago
amaratoure.135604 predicted that TRIL for 2020-01-23 is going

Rank:

4 years ago
Trevor Durand predicted that TRIL for 2020-01-23 is going

Rank:

4 years ago
2poJeff predicted that TRIL for 2020-01-23 is going $2.55 (-21.90%)

4 years ago
Laraan predicted that TRIL for 2020-01-23 is going $2.77 (-15.16%)

Rank:

4 years ago
JS predicted that TRIL for 2020-01-10 is going $3.27 (18.91%)

Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT